ADAR and chronic myelogenous leukemia, BCR-ABL1 positive: Functional studies demonstrated that ADAR-1-mediated RNA editing plays a role in the malignant reprogramming of myeloid progenitors into LSC that drive CML progression, by promoting the expression of the myeloid transcription factor PU.1 and producing misspliced isoforms of GSK3β [118].